摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methyl-1,2,3,4-tetrahydroisochinolin-1,4-dion | 90924-10-0

中文名称
——
中文别名
——
英文名称
3-Methyl-1,2,3,4-tetrahydroisochinolin-1,4-dion
英文别名
3-Methyl-2,3-dihydroisoquinoline-1,4-dione
3-Methyl-1,2,3,4-tetrahydroisochinolin-1,4-dion化学式
CAS
90924-10-0
化学式
C10H9NO2
mdl
——
分子量
175.187
InChiKey
VAXPFPYGNZQQTK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    46.2
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
    申请人:VERTEX PHARMACEUTICALS INCORPORATED
    公开号:EP2327701A1
    公开(公告)日:2011-06-01
    The present invention relates to compounds of formula (IV) useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及作为电压门控通道抑制剂的式 (IV) 化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
  • Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain
    申请人:VERTEX PHARMACEUTICALS INCORPORATED
    公开号:EP2332912A1
    公开(公告)日:2011-06-15
    The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    本发明涉及可用作电压门控通道抑制剂的化合物。本发明还提供了包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
  • [EN] COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS<br/>[FR] COMPOSITIONS UTILISEES COMME INHIBITEURS DE CANAUX SODIUM VOLTAGE DEPENDANTS
    申请人:VERTEX PHARMA
    公开号:WO2005013914A2
    公开(公告)日:2005-02-17
    The present invention relates to compounds such as those of formula (I-A) inhibitors of voltage-gated sodium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders, such as pain.
查看更多